Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.062x

Based on the latest financial reports, Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.57 Million ≈ $16.47 Million USD) by net assets (CN¥1.83 Billion ≈ $267.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang Anglikang Pharmaceutical Co Ltd (002940) market capitalisation for the company's overall valuation and market capitalisation.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Zhejiang Anglikang Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Anglikang Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency. Explore how high is Zhejiang Anglikang Pharmaceutical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Community West Bancshares NASDAQ:CWBC	0.018x
Chengdu Huaqi Houpu Holding Co Ltd SHE:300471	0.017x
Once Upon a Farm, PBC NYSE:OFRM	0.054x
REVO INSURANCE SPA O.N. F:H0O	N/A
Beijing Beilu Pharmaceutical SHE:300016	0.032x
J.S. Corrugating Machinery Co Ltd SHE:000821	0.038x
Stratasys Ltd NASDAQ:SSYS	0.006x
Kvutzat Acro Ltd. TA:ACRO	-0.030x

Annual Cash Flow Conversion Efficiency for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. View Zhejiang Anglikang Pharmaceutical Co Ltd (002940) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.87 Billion ≈ $273.23 Million	CN¥244.13 Million ≈ $35.72 Million	0.131x	-7.28%
2024-12-31	CN¥1.80 Billion ≈ $263.17 Million	CN¥253.60 Million ≈ $37.11 Million	0.141x	-6.69%
2023-12-31	CN¥1.83 Billion ≈ $268.12 Million	CN¥276.91 Million ≈ $40.52 Million	0.151x	+34.66%
2022-12-31	CN¥1.65 Billion ≈ $240.88 Million	CN¥184.75 Million ≈ $27.03 Million	0.112x	-16.25%
2021-12-31	CN¥1.47 Billion ≈ $215.83 Million	CN¥197.65 Million ≈ $28.92 Million	0.134x	-7.03%
2020-12-31	CN¥1.38 Billion ≈ $201.64 Million	CN¥198.61 Million ≈ $29.06 Million	0.144x	-31.38%
2019-12-31	CN¥1.02 Billion ≈ $148.74 Million	CN¥213.49 Million ≈ $31.24 Million	0.210x	+52.63%
2018-12-31	CN¥970.93 Million ≈ $142.08 Million	CN¥133.61 Million ≈ $19.55 Million	0.138x	-71.99%
2017-12-31	CN¥394.37 Million ≈ $57.71 Million	CN¥193.77 Million ≈ $28.36 Million	0.491x	+13.50%
2016-12-31	CN¥327.43 Million ≈ $47.91 Million	CN¥141.74 Million ≈ $20.74 Million	0.433x	-17.47%
2015-12-31	CN¥264.20 Million ≈ $38.66 Million	CN¥138.59 Million ≈ $20.28 Million	0.525x	+125.68%
2014-12-31	CN¥217.08 Million ≈ $31.77 Million	CN¥50.46 Million ≈ $7.38 Million	0.232x	--

About Zhejiang Anglikang Pharmaceutical Co Ltd Class A

SHE:002940 China Drug Manufacturers - Specialty & Generic

Market Cap

$683.66 Million

CN¥4.67 Billion CNY

Market Cap Rank

#10777 Global

#2959 in China

Share Price

CN¥23.16

Change (1 day)

+1.36%

52-Week Range

CN¥22.72 - CN¥47.00

All Time High

CN¥249286.54